Export your current network:
... as a bitmap image:
file format is 'PNG': portable network graphic
... as a high-resolution bitmap:
same PNG format, but at higher resolution
... as a vector graphic:
SVG: scalable vector graphic - can be opened and edited in Illustrator, CorelDraw, Dia, etc
... as short tabular text output:
TSV: tab separated values - can be opened in Excel and Cytoscape (lists only one-way edges: A-B)
... as tabular text output:
TSV: tab separated values - can be opened in Excel (lists reciprocal edges: A-B,B-A)
... as an XML summary:
structured XML interaction data, according to the 'PSI-MI' data standard
... protein node degrees:
node degree of proteins in your network (given the current score cut-off)
... network coordinates:
a flat-file format describing the coordinates and colors of nodes in the network
... protein sequences:
MFA: multi-fasta format - containing the aminoacid sequences in the network
... protein annotations:
a tab-delimited file describing the names, domains and descriptions of proteins in your network
... functional annotations:
a tab-delimited file containing all known functional terms of protiens in your network
Browse interactions in tabular form:
node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
Afap1l1 | ENSRNOP00000066837 | ENSRNOP00000026495 | ENSRNOP00000066837 | Actin filament-associated protein 1-like 1; May be involved in podosome and invadosome formation. | Serine peptidase inhibitor, Kazal type 14. | 0.470 |
Afap1l1 | Spink14-2 | ENSRNOP00000026495 | ENSRNOP00000041361 | Actin filament-associated protein 1-like 1; May be involved in podosome and invadosome formation. | Serine protease inhibitor Kazal-type 14; May be a serine protease inhibitor. | 0.470 |
Ccdc112 | ENSRNOP00000066837 | ENSRNOP00000004742 | ENSRNOP00000066837 | Similar to mutated in bladder cancer 1 (Predicted). | Serine peptidase inhibitor, Kazal type 14. | 0.471 |
Ccdc112 | Spink14-2 | ENSRNOP00000004742 | ENSRNOP00000041361 | Similar to mutated in bladder cancer 1 (Predicted). | Serine protease inhibitor Kazal-type 14; May be a serine protease inhibitor. | 0.471 |
Dtwd2 | ENSRNOP00000066837 | ENSRNOP00000075130 | ENSRNOP00000066837 | DTW domain-containing 2. | Serine peptidase inhibitor, Kazal type 14. | 0.470 |
Dtwd2 | Spink14-2 | ENSRNOP00000075130 | ENSRNOP00000041361 | DTW domain-containing 2. | Serine protease inhibitor Kazal-type 14; May be a serine protease inhibitor. | 0.470 |
ENSRNOP00000066837 | Afap1l1 | ENSRNOP00000066837 | ENSRNOP00000026495 | Serine peptidase inhibitor, Kazal type 14. | Actin filament-associated protein 1-like 1; May be involved in podosome and invadosome formation. | 0.470 |
ENSRNOP00000066837 | Ccdc112 | ENSRNOP00000066837 | ENSRNOP00000004742 | Serine peptidase inhibitor, Kazal type 14. | Similar to mutated in bladder cancer 1 (Predicted). | 0.471 |
ENSRNOP00000066837 | Dtwd2 | ENSRNOP00000066837 | ENSRNOP00000075130 | Serine peptidase inhibitor, Kazal type 14. | DTW domain-containing 2. | 0.470 |
ENSRNOP00000066837 | F1M0J8_RAT | ENSRNOP00000066837 | ENSRNOP00000030908 | Serine peptidase inhibitor, Kazal type 14. | Uncharacterized protein. | 0.454 |
ENSRNOP00000066837 | Spink14-2 | ENSRNOP00000066837 | ENSRNOP00000041361 | Serine peptidase inhibitor, Kazal type 14. | Serine protease inhibitor Kazal-type 14; May be a serine protease inhibitor. | 0.458 |
F1M0J8_RAT | ENSRNOP00000066837 | ENSRNOP00000030908 | ENSRNOP00000066837 | Uncharacterized protein. | Serine peptidase inhibitor, Kazal type 14. | 0.454 |
F1M0J8_RAT | Spink14-2 | ENSRNOP00000030908 | ENSRNOP00000041361 | Uncharacterized protein. | Serine protease inhibitor Kazal-type 14; May be a serine protease inhibitor. | 0.454 |
Spink14-2 | Afap1l1 | ENSRNOP00000041361 | ENSRNOP00000026495 | Serine protease inhibitor Kazal-type 14; May be a serine protease inhibitor. | Actin filament-associated protein 1-like 1; May be involved in podosome and invadosome formation. | 0.470 |
Spink14-2 | Ccdc112 | ENSRNOP00000041361 | ENSRNOP00000004742 | Serine protease inhibitor Kazal-type 14; May be a serine protease inhibitor. | Similar to mutated in bladder cancer 1 (Predicted). | 0.471 |
Spink14-2 | Dtwd2 | ENSRNOP00000041361 | ENSRNOP00000075130 | Serine protease inhibitor Kazal-type 14; May be a serine protease inhibitor. | DTW domain-containing 2. | 0.470 |
Spink14-2 | ENSRNOP00000066837 | ENSRNOP00000041361 | ENSRNOP00000066837 | Serine protease inhibitor Kazal-type 14; May be a serine protease inhibitor. | Serine peptidase inhibitor, Kazal type 14. | 0.458 |
Spink14-2 | F1M0J8_RAT | ENSRNOP00000041361 | ENSRNOP00000030908 | Serine protease inhibitor Kazal-type 14; May be a serine protease inhibitor. | Uncharacterized protein. | 0.454 |